These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 9675668)

  • 21. [The exacerbation of psoriasis during treatment with alfa interferon].
    Pellicano R; Puiatti P; Palmas P; Rizzetto M; Ponzetto A
    Recenti Prog Med; 1997 Sep; 88(9):423. PubMed ID: 9380948
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prolonged (24 weeks) treatment of chronic hepatitis type B with recombinant interferon-alpha].
    Matsuda H; Kashiwagi T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):629-34. PubMed ID: 12442457
    [No Abstract]   [Full Text] [Related]  

  • 23. [Consensus interferon. Problematic patients are not a problem].
    MMW Fortschr Med; 2001 Jun; 143(23):41. PubMed ID: 11460420
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The retreatment with natural leukocyte interferon alfa-n3 of chronic hepatitis C patients: the intolerant and nonresponsive results to prior treatment with recombinant alfa interferon].
    Cagnoni C; Pancotti D; Carrara G
    Ann Ital Med Int; 1999; 14(3):159-65. PubMed ID: 10566181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of patients with HCV infection poorly tolerant to recombinant interferon alpha.
    Cagnoni C; Pancotti D; Carrara G
    Hepatogastroenterology; 2000; 47(31):199-203. PubMed ID: 10690609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study.
    Ascione A; De Luca M; Canestrini C; Di Costanzo GG; Raimondo G; Longo G; Manns MP; Tillmann HL; Forte GB; Rocco P; Biceglia O; Faleo D; Vinelli F; Cela EM; Amitrano L; Addario L; Gigliotti T
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):517-23. PubMed ID: 9836109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up.
    Spadaro A; Freni MA; Ajello A; Alessi N; Barbaro E; Resta ML; Ferraü O
    Hepatogastroenterology; 1999; 46(30):3229-33. PubMed ID: 10626191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of interferon-alpha in hematological diseases].
    Nerl C
    Dtsch Med Wochenschr; 1995 Sep; 120(36):1209-11. PubMed ID: 7671773
    [No Abstract]   [Full Text] [Related]  

  • 30. Retreatment with human leukocyte interferon alpha of chronic hepatitis C, recurring after a first cycle with recombinant interferon.
    Carrara M; Azzurro M; Adamo S
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):234-5. PubMed ID: 9675668
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.